| ACUIX | RMFCX | ACUIX / RMFCX | |
| Total Expense Ratio | 1.78 | 0.91 | 196% |
| Annual Report Gross Expense Ratio | 1.78 | 0.91 | 196% |
| Fund Existence | 26 years | 24 years | - |
| Gain YTD | 19.115 | 11.975 | 160% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2000 | 250 | 800% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.63B | 118B | 2% |
| Annual Yield % from dividends | 1.55 | 1.15 | 135% |
| Returns for 1 year | 19.98 | 10.11 | 198% |
| Returns for 3 years | 43.25 | 37.68 | 115% |
| Returns for 5 years | 28.65 | 38.12 | 75% |
| Returns for 10 years | 44.52 | 94.39 | 47% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MSFU | 37.72 | 0.64 | +1.73% |
| Direxion Daily MSFT Bull 2X Shares | |||
| WAMA | 27.30 | 0.19 | +0.71% |
| WisdomTree U.S. Adaptive Moving Average | |||
| FLOT | 50.95 | 0.02 | +0.04% |
| iShares Floating Rate Bond ETF | |||
| QMAG | 25.67 | N/A | +0.02% |
| FT Vest Nasdaq-100 Mod Buffr ETF - Aug | |||
| IBRN | 39.57 | N/A | N/A |
| iShares Neuroscience and Healthcare ETF | |||